Brighton and Sussex Medical School, Brighton, UK.
Department of Primary Care and Public Health, Brighton and Sussex Medical School, Brighton, UK.
Nat Commun. 2024 Feb 22;15(1):1619. doi: 10.1038/s41467-024-45355-3.
The Consolidated Standards of Reporting Trials extension for Artificial Intelligence interventions (CONSORT-AI) was published in September 2020. Since its publication, several randomised controlled trials (RCTs) of AI interventions have been published but their completeness and transparency of reporting is unknown. This systematic review assesses the completeness of reporting of AI RCTs following publication of CONSORT-AI and provides a comprehensive summary of RCTs published in recent years. 65 RCTs were identified, mostly conducted in China (37%) and USA (18%). Median concordance with CONSORT-AI reporting was 90% (IQR 77-94%), although only 10 RCTs explicitly reported its use. Several items were consistently under-reported, including algorithm version, accessibility of the AI intervention or code, and references to a study protocol. Only 3 of 52 included journals explicitly endorsed or mandated CONSORT-AI. Despite a generally high concordance amongst recent AI RCTs, some AI-specific considerations remain systematically poorly reported. Further encouragement of CONSORT-AI adoption by journals and funders may enable more complete adoption of the full CONSORT-AI guidelines.
2020 年 9 月发布了人工智能干预措施的临床试验报告标准(CONSORT-AI)扩展版。自发布以来,已经发表了几项人工智能干预措施的随机对照试验(RCT),但它们的报告完整性和透明度尚不清楚。本系统评价评估了 CONSORT-AI 发布后人工智能 RCT 的报告完整性,并对近年来发表的 RCT 进行了全面总结。确定了 65 项 RCT,主要在中国(37%)和美国(18%)进行。与 CONSORT-AI 报告的中位数一致性为 90%(IQR77-94%),尽管只有 10 项 RCT 明确报告了其使用情况。一些项目始终报告不足,包括算法版本、人工智能干预措施或代码的可及性,以及对研究方案的引用。52 种纳入期刊中只有 3 种明确支持或要求使用 CONSORT-AI。尽管最近的人工智能 RCT 之间总体上具有较高的一致性,但一些人工智能特定的考虑因素仍系统地报告不足。期刊和资助者进一步鼓励采用 CONSORT-AI 可能会使完整的 CONSORT-AI 指南得到更全面的采用。